Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2020 09:00 ET | Source: MEDO.AI

MEDO.ai receives FDA approval to automatically detect hip dysplasia, preventing the leading cause of early hip osteoarthritis and hip replacement surgery

EDMONTON, Alberta, June 16, 2020 (GLOBE NEWSWIRE) -- MEDO.ai, an artificial intelligence technology start-up company dual headquartered in Edmonton, Canada, and Singapore, is pleased to...